THERAPEUTIC COMPOUNDS Russian patent published in 2012 - IPC C07C39/06 C07C39/26 C07C37/00 C07C37/01 C07C37/05 C07C37/55 C07C271/44 A61K31/05 A61P1/08 A61P23/00 A61P25/20 

Abstract RU 2470907 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to a new (-)-stereoisomer of formula (I) wherein X is H, or its pharmaceutically acceptable salt which agonise GABA receptor, to a pharmaceutical composition on the basis of the presented compound, to a method for preparing the (-)-stereoisomer of formula (I) or its pharmaceutically acceptable salt, to a method for inducing or maintaining general anaesthesia, to a method for promoting pain management and to a method for promoting pain management and to a method for prototyping antiemetic activity with the use of the presented (-)-stereoisomer or its pharmaceutically acceptable salt, as well as to a new diastereoisomer (-)-2-fluoro-butyl-6-isopropylphenyl ester of carbamic acid of formula (II) wherein R1 represents a chiral amino group, and X is H.

EFFECT: preparing the pharmaceutically acceptable salt which agonise GABA receptor.

16 cl, 12 ex, 6 tbl, 4 dwg

Similar patents RU2470907C2

Title Year Author Number
THERAPEUTIC COMPOUNDS 2008
  • Dzhenkins Tomas Eh.
RU2470908C2
PHARMACEUTICAL COMPOSITION CONTAINING WATER SOLUBLE PROPOPHOL PRODRUGS AND USES THEREOF 2003
  • Vingard Peggi
  • B'Jurak Ehrik S.
  • Dzhibianski Ekaterina
  • Vornov Dzhejms Dzh.
RU2297216C2
ETOMIDATE ANALOGUES WITH IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES 2009
  • Rejnz Duglas E.
  • Forman Stjuart A.
  • Miller Kejt V.
  • Khusejn Sajed Shaukat
  • Kotten Dzhozef F.
RU2540116C2
ANAESTHETIC COMPOSITION 2011
  • Goodchild Juliet Marguerite
  • Goodchild Colin Stanley
  • Boyd Benjamin James
RU2574022C2
ETOMIDATE ANALOGUES WHICH DO NOT INHIBIT SYNTHESIS OF ADRENOCORTICOSTEROIDS 2010
  • Raines Douglas E.
  • Cotten Joseph F.
  • Forman Stuart A.
  • Miller Keith W.
  • Husain Syed S.
  • Cuny Gregory D.
RU2559888C2
COMPOUNDS, METHODS FOR THEIR PREPARING, USING, PHARMACEUTICAL COMPOSITION 2002
  • Tegtmajer Frank
  • Janssens Frans Ehduard
  • Lenarts Jozef Ehlizabet
  • Van Rossem Kunrad Artur
  • Al'Kasar-Vaka Manuehl' Khesus
  • Martines-Khimenes Pedro
  • Bartolome-Nebreda Khose Manuehl'
  • Gomes-Sanches Antonio
  • Fernandes-Gadea Fransisko Khav'Er
  • Van Rempts Jozef Leo Khenri
RU2311418C2
2-(2-AMINO-1,6-DIHYDRO-6-OXOPURIN-9-YL)METOXY-3-HYDROXY- 1-PROPANYL-L-VALINATE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD OF PREPARING THEREOF, PHARMACEUTICAL COMPOSITION AND HYDROXY AND/OR AMINO PROTECTED 2-(2- AMINO-1,6-DIHYDRO-6-OXOPYRIN-9-YL) METHOXY-3-HYDROXY-1- PROPANYL-L-VALINATE 1995
  • Dzhon Dzh.Nestor
  • Skott V.Vombl
  • Khans Maag
RU2133749C1
PRODRUGS OF ALVOCIDIB HAVING HIGH BIOAVAILABILITY 2016
  • Siddiqui-Jain Adam
  • Bearss David J.
RU2752729C2
METHOD OF TREATMENT BY APPLICATION OF COMBINED THERAPY 2010
  • Armstrong Robert K.
  • Belli Barbara A.
RU2543348C2
PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS 2013
  • Perejra Devid E.
  • Vu Sara
  • Fernandes Prabkhavati
RU2658050C2

RU 2 470 907 C2

Authors

Dzhenkins Tomas Eh.

Dates

2012-12-27Published

2008-05-08Filed